← Back to Search

Other

Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

N/A
Waitlist Available
Led By Enoch Huang, MD
Research Sponsored by Legacy Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether hyperbaric oxygen therapy can help COVID-19 patients with low oxygen levels by increasing the amount of oxygen in their blood. The goal is to see if this treatment can reduce deaths and the need for ventilators. Hyperbaric oxygen therapy (HBOT) has been explored as a treatment for COVID-19 patients, showing potential benefits in improving oxygenation and reducing inflammation.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of 60-Day Patient Mortality
Secondary study objectives
Number of Participants Displaying Presence of Any Pulmonary Function Abnormality
Number of Patients with Ongoing Clinical Symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hyperbaric OxygenExperimental Treatment1 Intervention
Hyperbaric Oxygen Therapy (HBOT) + Standard of Care (SOC) as defined by current best practice treatments for COVID-19
Group II: Standard of CareActive Control1 Intervention
Standard of Care (SOC) as defined by current best practice treatments for COVID-19
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric Oxygen Therapy (HBOT)
2008
N/A
~170

Find a Location

Who is running the clinical trial?

Legacy Health SystemLead Sponsor
35 Previous Clinical Trials
3,654 Total Patients Enrolled
Enoch Huang, MD5.02 ReviewsPrincipal Investigator - Legacy Research Institute
Legacy Health System
2 Previous Clinical Trials
25 Total Patients Enrolled
5Patient Review
Dr. Huang is an excellent doctor. He is very honest and open with me about my health, and he is very responsive to my needs.
~6 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top